The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Cardiac Valve Global Market Report 2024, the cardiac valve market is expected to show promising growth in the forecast period.

Current Scenario and Growth Projections
The cardiac valve market has witnessed remarkable growth in recent years, with the market size surging from $9.68 billion in 2023 to $11.17 billion in 2024, showcasing a compound annual growth rate (CAGR) of 15.3%. The forecast predicts a continued upward trajectory, reaching $18.87 billion in 2028 at a CAGR of 14.0%.

2.  Factors Driving Growth in the Historic Period

• Aging Population and Valvular Heart Disease
• Increased Prevalence of Risk Factors (Obesity and Hypertension)
• Improved Diagnostic Technologies
• Awareness Campaigns on Heart Health
• Development of Minimally Invasive Procedures

3.  Forecasted Growth Drivers

• Demand for Bioengineered and Tissue-Engineered Heart Valves
• Aging Global Population
• Telemedicine for Valve Patients
• Advanced Surgical Techniques and Robotics
• Adoption of 3D Printing for Personalized Valve Manufacturing

4. Major Trends Shaping the Forecast Period

• Advancements in Valve Replacement and Repair Techniques
• Integration of Artificial Intelligence (AI) in Detection and Treatment
• Adoption of 3D Printing for Personalized Manufacturing
• Enhanced Surgical Techniques and Robotics-Assisted Procedures

Addressing the Growing Burden of Heart-Related Ailments
The increasing incidence of cardiovascular diseases is a key driver for the expansion of the cardiac valve market. Factors such as smoking, obesity, and a sedentary lifestyle contribute to a rise in heart-related ailments, necessitating the use of cardiac valves for treatment.

In September 2023, the World Health Organization reported 41 million deaths annually due to non-communicable diseases, with 74% attributed to chronic diseases. Cardiovascular diseases accounted for 17.9 million deaths, highlighting the pressing need for effective cardiac valve solutions. Major companies contributing to this market include LivaNova PLC, Abbott Laboratories, and Edwards Lifesciences Corporation.

View More On The Cardiac Valve Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Next-Generation Tavi Systems Redefining The Cardiac Valve Market
Leading companies in the cardiac valve market are investing in innovative products, particularly next-generation transcatheter aortic valve implantation (TAVI) systems. These advancements aim to drive revenues and offer intelligent design advantages for improved patient outcomes.

For example, Abbott launched the Navitor TAVI system in December 2022, catering to patients with severe native aortic stenosis at high or extreme risk for open-heart surgery. This system boasts features like smart PVL-sealing NaviSeal Cuff, accurate placement, low gradients, and excellent access, showcasing a commitment to superior outcomes across various anatomies.

Venus MedTech’s Strategic Expansion With The Acquisition Of Cardiovalve Ltd.
In January 2022, Venus Medtech, a China-based company specializing in structural heart disease treatment, acquired Cardiovalve Ltd. This strategic move positions Venus Medtech as a comprehensive platform for treating mitral and tricuspid regurgitation. Cardiovalve Ltd., based in Israel, focuses on developing a transfemoral mitral valve replacement system.

Segmenting the Market for a Holistic Understanding
The cardiac valve market is segmented based on various criteria, providing a comprehensive perspective for stakeholders:

1. By Type:
   • Tissue Heart Valves
   • Transcatheter Heart Valves
   • Mechanical Heart Valves
   • Other Types
2. By Position:
   • Aortic Valve
   • Mitral Valve
   • Other Positions
3. By Treatment:
   • Cardiac Valve Repair
   • Cardiac Valve Replacement
4. By End-Users:
   • Hospital And Clinics
   • Specialty Centers
   • Cardiac Research Institute
   • Other End Users

Regional Dynamics
In 2023, North America emerged as the largest region in the cardiac valve market, while Asia-Pacific is anticipated to be the fastest-growing region in the forecast period, further emphasizing the global nature of this expanding market.

In conclusion, the cardiac valve market is poised for significant growth, driven by a combination of demographic shifts, technological advancements, and innovative solutions. The continuous evolution of next-generation technologies and strategic acquisitions positions the industry to address the evolving landscape of heart-related ailments effectively.

Request A Sample Of The Global Cardiac Valve Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7753&type=smp